Bank of America’s Inovio Pharmaceuticals INO Stock Holding History

Bank of America’s Portfolio INO Stock Details INO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-6,400	Closed	-$550K	–	8401
2021 Q3	$550K	Sell	6,400 -6,875	-52%	-$690K	﹤0.01%	5578
2021 Q2	$1.48M	Sell	13,275 -7,642	-37%	-$734K	﹤0.01%	4564
2021 Q1	$2.33M	Buy	+20,917	New	+$2.75M	﹤0.01%	4130
2020 Q4	–	Sell	-81,475	Closed	-$11.3M	–	7206
2020 Q3	$11.3M	Buy	81,475 +73,142	+878%	+$15.3M	﹤0.01%	2187
2020 Q2	$2.69M	Buy	+8,333	New	+$1.34M	﹤0.01%	3386

Other funds holding INO

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

BCM

Boxer Capital Management San Diego, California $762M AUM 1,125.36% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

ACM

ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of America's INO Position: Q1 2026 in Review

Bank of America reduced its Inovio Pharmaceuticals (INO) stake by 50% in Q1 2026, selling an estimated $54.5K and leaving 32,677 shares worth $56.9K. The position accounts for ﹤0.01% of the portfolio, ranked #5584.

Bank of America first reported a position in INO in Q2 2013 and has held it in 52 quarters since. The position peaked at $12.8M in Q3 2020. 100 funds tracked by Wall St. Rank hold INO as of Q1 2026.

Bank of America held 32,677 shares of Inovio Pharmaceuticals worth $56.9K as of Q1 2026.
Bank of America sold 33,109 Inovio Pharmaceuticals shares in Q1 2026, an estimated $54.5K.
Inovio Pharmaceuticals made up ﹤0.01% of Bank of America's portfolio in Q1 2026, its #5584 holding.
Bank of America first reported a position in Inovio Pharmaceuticals in Q2 2013 and has held it in 52 quarters since.
Bank of America's Inovio Pharmaceuticals position peaked at $12.8M in Q3 2020.
100 funds tracked by Wall St. Rank held Inovio Pharmaceuticals as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.